Today: 9 April 2026
Cambricon (688256) stock in focus after AI chipmaker flags first annual profit, with Monday open next
2 February 2026
1 min read

Cambricon (688256) stock in focus after AI chipmaker flags first annual profit, with Monday open next

Shanghai, Feb 2, 2026, 07:57 GMT+8 — Premarket

  • On Jan. 30, shares ended at 1,258.89 yuan, rising 0.55%
  • Exchange filing projects 2025 net profit between 1.85 billion and 2.15 billion yuan, with revenue expected to hit 6 to 7 billion yuan
  • Traders are focused on Monday’s open and the audited annual report set for release in March

Cambricon Technologies Corp Ltd’s Class A shares (688256.SS) head into Monday’s session following the AI chip maker’s forecast of a full-year profit in 2025. The stock closed last at 1,258.89 yuan, up 0.55%, with 6.35 million shares changing hands. Over the past year, the price has swung between 520.67 and 1,595.88 yuan. Investing.com

The forecast is crucial now since the stock trades on the tech-heavy STAR Market, where hitting profit targets can shift investor sentiment. According to Shanghai Stock Exchange rules, companies that go public before turning a profit get tagged with a “U” (unprofitable) marker in their stock names. SSE

Cambricon projected a net profit attributable to shareholders between 1.85 billion and 2.15 billion yuan in a Jan. 31 exchange filing, a sharp turnaround from a 452.3 million yuan loss in 2024. The company also forecast revenue climbing to 6 billion to 7 billion yuan, up from just 1.17 billion yuan the previous year. Net profit excluding non-recurring items was expected to hit between 1.6 billion and 1.9 billion yuan. The firm noted these figures are preliminary and unaudited. Cnstock

Cambricon attributed its turnaround to a “continued rise in computing power demand” across the AI sector, adding that stronger product competitiveness helped expand its market presence.

The filing comes amid a surge in Chinese chipmakers targeting AI data centre demand and a government push to ramp up domestic sourcing, as Nvidia’s top-tier chips stay tight. The South China Morning Post noted several Chinese semiconductor firms posted strong profits for 2025, fueled by their role in that expansion. South China Morning Post

On Feb. 1, analysts Fang Jing and Lu Wei from Guolian Minsheng Securities noted that increased spending from top domestic cloud vendors might sustain demand for local computing chips. 发现报告

Cambricon develops AI processors aimed at cloud and edge computing markets and offers accompanying software, per its company profile. Reuters

But that forecast isn’t set in stone. Profit could still take a hit from audit revisions, slower customer demand, or tougher pricing. The stock’s broad 52-week range highlights just how fast sentiment can swing in the crowded “domestic compute” space.

The next major event to watch is the audited annual report. According to Investing.com’s market calendar, the upcoming earnings release is set for March 13. Investing.com

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:10 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Infineon stock price: IFX heads into earnings week after a soft close — what to watch next
Previous Story

Infineon stock price: IFX heads into earnings week after a soft close — what to watch next

Zhongji Innolight stock price in focus: profit forecast, 1.6T orders and what could move the A-shares next
Next Story

Zhongji Innolight stock price in focus: profit forecast, 1.6T orders and what could move the A-shares next

Go toTop